Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 334, Issue 4, pp 463–467 | Cite as

Prostanoid synthesis by the rat urinary bladder: evidence for stimulation through muscarine receptor-linked calcium channels

  • J. Y. Jeremy
  • D. P. Mikhailidis
  • P. Dandona


An in vitro model for the study of muscarine receptor-mediated synthesis of prostacyclin (PGI2) and other prostanoids (PGE2 and PGF2α) by the rat urinary bladder is described. PGI2 synthesis was stimulated by parasympathomimetic agents (carbachol > methacholine > arecoline; McNA 343, nicotine and dimethyl phenyl piperazinium were without effect). Methacholine (3×10−6 mol·l−1)-stimulated PGI2 synthesis was inhibited by muscarinic antagonists (atropine > ipratroprium bromide > gallamine > pirenzepine) and was completely abolished by the presence of ethylene diamine tetraacetic acid (EDTA: 10 mmol·l−1). Verapamil also inhibited methacholine-stimulated PGI2 synthesis in a dose-dependent manner. The antagonistic action of atropine was shown to be competitive, but had no effect on calcium ionophore A23187-stimulated PGI2 synthesis. High concentrations of [K+] (up to 0.11 mol·l−1) were without effect on PGI2 synthesis. PGE2, PGF2α and PGI2 synthesis were all equally stimulated with methacholine, carbachol, arecoline and A23187, and methacholine-stimulated synthesis of these prostanoids was equally inhibited by atropine, ipratroprium bromide, gallamine, verapamil and EDTA.

It is concluded that in vitro prostanoid synthesis by the rat urinary bladder: (i) is stimulated by post ganglionic muscarine receptors; (ii) involves a muscarine receptorlinked calcium influx system; and (iii) is mediated by a predominance of M2 subtype receptors.

Key words

Urinary bladder Prostacyclin Prostaglandin E2 Prostaglandin F2α Muscarine receptors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdel-Hakim AM, Rioux F, Elhilali MA (1981) The contractile effect of bombesin on the rat isolated urinary bladder. Eur J Pharmacol 70:167–173Google Scholar
  2. Abrams PH, Feneley RCL (1976) The actions of prostaglandins on the smooth muscle of the human urinary tract in vitro. Br J Urol 47:909–915Google Scholar
  3. Andersson KE, Ek A, Persson CG (1977) Effects of prostaglandins on the isolated human bladder and urethra. Acta Physiol Scand 100:165–171Google Scholar
  4. Birdsall NJM, Hulme EC (1983) Muscarinic receptor subclasses. Trends Pharmacol Sci 4:459–463Google Scholar
  5. Bultitude MI, Hills NH, Shuttleworth KED (1976) Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors. Br J Urol 48:631–637Google Scholar
  6. Carpenter FH (1963) Excitation of rat urinary bladder by co-axial electrodes and by chemical agents. Am J Physiol 204:727–731Google Scholar
  7. Gaion RM, Trento M (1983) The role of prostacyclin on detrusor modulating cholinergic neurotransmission in guinea pig ileum. Br J Pharmacol 80:279–286Google Scholar
  8. Golub MS, Berger ME, Powell M (1985a) Adrenergic stimulation of prostacyclin production in the rat tail artery. I. Response to agonists and antagonists. Prostaglandins Leukotrienes Med 20:299–311Google Scholar
  9. Golub MS, Berger ME, Caunazzola AE (1985b) Adrenergic stimulation of prostacyclin in the rat tail artery. II. The role of calcium. Prostaglandins Leukotrienes Med 20:313–324Google Scholar
  10. Hammer R, Giachetti A (1982) Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterisation. Life Sci 31:2994–2998Google Scholar
  11. Hukovic S, Rand MJ, Vanov S (1965) Observations on an isolated innervated preparation of rat urinary bladder. Br J Pharmacol 24:178–188Google Scholar
  12. Irvine RF (1982) How is the level of free arachidonic acid controlled in mammalian cells. Biochemistry J 204:3–16Google Scholar
  13. Jeremy JY, Mikhailidis DP, Dandona P (1984a) The rat urinary bladder produces prostacyclin as well as other prostaglandins. Prostaglandins Leukotrienes Med 16:23248Google Scholar
  14. Jeremy JY, Mikhailidis DP, Dandona P (1984b) Vascular trauma and prostacyclin release. Microcircul Endothel Lymphatics 1:629–644Google Scholar
  15. Jeremy JY, Mikhailidis DP, Dandona P (1985a) Adrenergic modulation of vascular prostacyclin (PGI2) secretion. Eur J Pharmacol 114:33–40Google Scholar
  16. Jeremy JY, Mikhailidis DP, Dandona P (1985b) Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis. Eur J Pharmacol 107:259–262Google Scholar
  17. Jeremy JY, Mikhailidis DP, Dandona P (1985c) Cigarette smoke extracts inhibit prostacyclin synthesis by the rat urinary bladder. Br J Cancer 51:837–842Google Scholar
  18. Jeremy JY, Mikhailidis DP, Thompson CS, Barradas MA, Dandona P (1985d) Prostacyclin synthesis by the rat urinary bladder and aorta in experimental diabetes mellitus. Diabetes Res Clin Pract (Suppl) 1:S269Google Scholar
  19. Jeremy JY, Mikhailidis DP, Dandona P (1986a) The effect of nifedipine, nimodipine and nisoldipine on agonist- and traumastimulated prostacyclin synthesis in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 332:70–73Google Scholar
  20. Jeremy JY, Mikhailidis DP, Dandona P (1986b) Muscarinic stimulation of prostacyclin synthesis by the rat penis. Eur J Pharmacol 123:67–71Google Scholar
  21. Jeremy JY, Morgan RJ, Mikhailidis DP, Dandona P (1986c) Prostacyclin synthesis by the corpora cavernosa of the human penis: evidence for muscarinic control and pathological implications. Prostaglandis Leukotrienes Med 23:211–216Google Scholar
  22. Khanna OP, Barbieri EJ, McMichael R (1978) Effects of prostaglandins on vesicourethral smooth muscle of rabbit. Urology 12:674–671Google Scholar
  23. Lands WEM (1979) The biosynthesis and metabolism of prostaglandins. Ann Rev Physiol 41:633–652Google Scholar
  24. Lepor H, Kuhar MJ (1984) Characterization of muscarinic cholinergic receptor binding in thevas deferens, bladder, prostate and penis of the rabbit. J Urol 132:392–396Google Scholar
  25. Leslie CA, Pavlakis AJ, Wheeler JS, Siroky MB, Krane RJ (1984) Release of arachidonate cascade products by the rabbit bladder; neurophysiological significance. J Urol 132:876–879Google Scholar
  26. Moncada S, Vane JR (1979) Prostacyclin formation and effects. In: Roberts SM, Schneiman F (eds) Chemistry, biochemistry and pharmacological activity of prostanoids. Pergamon Press, Oxford, pp 258–73Google Scholar
  27. Omini C, Moncada S, Vane JR (1977) The effect of prostacyclin (PGI2) on tissues which detect prostaglandins. Prostaglandins 14:625–632Google Scholar
  28. Roszkowski AP (1961) an unusual type of sympathetic ganglionic stimulation, J Pharmacol Exp Ther 132:156–170Google Scholar
  29. Van Nueten JM, Vanhoutte PM (1981) Calcium entry blockers and vascular smooth muscle heterogeneity. Fed Proc 40:2862–2865Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • J. Y. Jeremy
    • 1
  • D. P. Mikhailidis
    • 1
  • P. Dandona
    • 1
  1. 1.Metabolic Unit, Department of Chemical Pathology and Human MetabolismRoyal Free Hospital and School of MedicineLondonUK

Personalised recommendations